FHJVX
Price
$44.56
Change
-$0.51 (-1.13%)
Updated
Nov 18 closing price
Net Assets
928.62M
VESIX
Price
$42.25
Change
-$0.38 (-0.89%)
Updated
Nov 18 closing price
Net Assets
35.25B
Interact to see
Advertisement

FHJVX vs VESIX

Header iconFHJVX vs VESIX Comparison
Open Charts FHJVX vs VESIXBanner chart's image
Fidelity Advisor Europe M
Price$44.56
Change-$0.51 (-1.13%)
VolumeN/A
Net Assets928.62M
Vanguard European Stock Instl
Price$42.25
Change-$0.38 (-0.89%)
VolumeN/A
Net Assets35.25B
FHJVX vs VESIX Comparison Chart in %
View a ticker or compare two or three
VS
FHJVX vs. VESIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHJVX is a Hold and VESIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VESIX has more cash in the bank: 35.3B vs. FHJVX (929M). VESIX pays higher dividends than FHJVX: VESIX (2.90) vs FHJVX (2.04). FHJVX was incepted earlier than VESIX: FHJVX (12 years) vs VESIX (26 years). FHJVX (1.17) is less costly to investors than VESIX (0.06). FHJVX is a more actively managed with annual turnover of: 31.00 vs. VESIX (3.00). FHJVX has a lower initial minimum investment than VESIX: FHJVX (0) vs VESIX (5000000). FHJVX annual gain was more profitable for investors over the last year : 29.87 vs. VESIX (23.21). VESIX return over 5 years is better than : 40.23 vs. FHJVX (20.32).
FHJVXVESIXFHJVX / VESIX
Total Expense Ratio1.170.061,950%
Annual Report Gross Expense Ratio1.170.061,950%
Fund Existence12 years26 years-
Gain YTD29.54925.995114%
Front Load4%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets929M35.3B3%
Annual Yield % from dividends2.042.9070%
Returns for 1 year29.8723.21129%
Returns for 3 years55.0246.06119%
Returns for 5 years20.3240.2351%
Returns for 10 years31.7960.6952%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQT27.281.11
+4.24%
Arcutis Biotherapeutics
AQST5.910.09
+1.46%
Aquestive Therapeutics
FSLR252.19-1.35
-0.53%
First Solar
FRD20.26-0.23
-1.12%
Friedman Industries Inc
SINT3.30-0.19
-5.44%
SiNtx Technologies Inc.